Form 4: Director Equity Transactions at Eastman Chemical

Brett D. Begemann, a Director at Eastman Chemical Co., reported transactions involving phantom stock units on April 8, 2026.

Summary

• Director Brett D. Begemann of Eastman Chemical Co. (EMN) engaged in transactions on April 8, 2026, related to phantom stock units.
• These phantom stock units are part of the Directors' Deferred Compensation Plan and are valued equivalent to the market price of one share of the issuer's common stock.
• The units are payable only in cash upon termination of service as a director.
• Transactions include the crediting of 1,159 phantom stock units and 408 phantom stock units.
• These units represent a voluntary and automatic deferral of director retainer fees.
• Dividend equivalents have been reinvested into additional phantom stock units.
• Beneficial ownership of common stock is reported as 56,970 and 58,408 shares, with ownership form listed as direct.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details routine director compensation transactions rather than significant financial performance or strategic shifts.

Positives

• Director Begemann's participation in the deferred compensation plan indicates continued commitment and alignment with the company's long-term performance.
• The reinvestment of dividend equivalents suggests a strategy to maximize long-term equity value.
• The transactions are structured as deferrals of compensation, which can be a positive sign of financial planning by the director.

Negatives

• The filing does not contain any negative financial results or operational setbacks.

Risks

• The value of the phantom stock units is directly tied to the market price of Eastman Chemical's common stock, exposing the director to market volatility.
• Payment is contingent upon termination of service as a director, introducing a potential risk if service is interrupted unexpectedly.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding future financial performance. The transactions reflect ongoing compensation and deferral plans.

Management Comments

• Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director.
• Voluntary deferral of a portion of director's retainer fees that would otherwise have been paid in cash.
• Includes dividend equivalents reinvested in additional Phantom Stock Units.
• Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan.

Industry Context

StockSavvy.ai notes that the use of phantom stock units and deferred compensation plans is a common practice among large-cap companies in the chemical industry to attract and retain experienced directors and align their interests with shareholders.

Related Party Transactions

• Transactions involve Brett D. Begemann, a Director of Eastman Chemical Co., and the company's Directors' Deferred Compensation Plan.

Stakeholder Impact

• Shareholders: The transactions reflect standard director compensation practices, aligning director interests with stock performance through deferred equity.
• Employees: No direct impact on employees is indicated by this filing.
• Creditors: No impact on creditors is indicated.
• Suppliers: No impact on suppliers is indicated.
• Customers: No impact on customers is indicated.

Next Steps

• Payment of phantom stock units in cash upon termination of service as a director.

Key Dates

Keywords

Eastman Chemical, EMN, Form 4, Director, Phantom Stock Units, Deferred Compensation, Beneficial Ownership, Equity Transaction, SEC Filing